Incyte is a biopharmaceutical company focused on providing innovative solutions for unmet medical needs. With a passion for scientific excellence, they strive to develop breakthrough therapies to improve the lives of patients. Incyte's diverse portfolio includes molecules in development, clinical trials, and approved therapies in both oncology and dermatology.

At Incyte, they believe that every challenge is an opportunity for a breakthrough. Their international presence spans across North America and Europe, with headquarters in Denmark and operations in Italy, Spain, the United Kingdom, Finland, Japan, Sweden, Austria, France, the Netherlands, Switzerland, Canada, Germany, Norway, and Portugal. In addition to their commitment to patients, Incyte values their team of passionate individuals who bring ideas to life and tackle the toughest challenges.

They also provide patient resources as a source of information and support. Stay updated with their latest news and investor information through their investor resources and press releases. Join Incyte in their mission to Solve On and make a meaningful impact on the medical field